Shifting to a non-vitamin K antagonist oral anticoagulation agent from vitamin K antagonist in atrial fibrillation

Fosbol, EL; Vinding, NE; Lamberts, M; Staerk, L; Gundlund, A; Gadsboll, K; Kober, L; Gislason, GH; Olesen, JB

Fosbol, EL (reprint author), Copenhagen Univ Hosp Herlev & Gentofte, Dept Cardiol, Post 635,Kildegaardsvej 28, DK-2900 Hellerup, Denmark.; Fosbol, EL (reprint author), Danish Heart Fdn, Vognmagergade 7, DK-1120 Copenhagen, Denmark.; Fosbol, EL (reprint au

EUROPACE, 2018; 20 (6): E78

Abstract

Aims After non-vitamin K antagonist (VKA) oral anticoagulation agents (NOAC) have been approved for thromboembolic prophylaxis in non-valvular atrial ......

Full Text Link